TY - JOUR
T1 - Provider Perspectives on and Access to Palliative Care for Patients With Interstitial Lung Disease
AU - Pulmonary Fibrosis Foundation
AU - Gersten, Rebecca A.
AU - Seth, Bhavna
AU - Arellano, Luis
AU - Shore, Jessica
AU - O'Hare, Lanier
AU - Patel, Nina
AU - Safdar, Zeenat
AU - Krishna, Rachana
AU - Mageto, Yolanda
AU - Cochran, Darlene
AU - Lindell, Kathleen
AU - Danoff, Sonye K.
AU - Patel, Divya
AU - Whelan, Timothy P.M.
AU - Adams, Traci
AU - Reichuber, Janell
AU - Russell, Tonya
AU - Bachert, Heather
AU - Luckhardt, Tracy R.
AU - Morrison, Lake
AU - Dematte, Jane E.
AU - Gripaldo, Ria Edwina
AU - Henderson, Michael
AU - Thavarajah, Krishna
AU - Tomic, Rade
N1 - Publisher Copyright:
© 2022 American College of Chest Physicians
PY - 2022/8
Y1 - 2022/8
N2 - Background: Interstitial lung disease (ILD) results in profound symptom burden and carries high mortality. Palliative care (PC) is dedicated to improving quality of life in patients with serious illness. Early PC provision improves rates of advance care planning and symptom management in patients with ILD. Research Question: What are the current perspectives on PC among ILD providers, and what are the barriers to PC in ILD specialty centers? Study Design and Methods: A 24-question electronic survey was disseminated to providers at the 68 Pulmonary Fibrosis Foundation Care Centers across the United States from October 2020 to December 2020. Results: The survey was completed by 128 participants representing all 68 Pulmonary Fibrosis Foundation Care Center Network sites. Most respondents were physicians. Most providers exhibit good knowledge of, feel comfortable assessing a patient's readiness for, and agree with the need for PC for patients with ILD. Providers are most likely to refer to PC at objective disease and/or symptomatic progression rather than at initial diagnosis. In comparison with providers who report referring their patients to PC, providers who report rare referral are more likely to cite lack local PC availability (P <.01) and less likely to feel comfortable discussing prognosis/disease trajectory (P =.03) or feel it is important to address advance directives in ILD clinic (P =.02). There is a lack of standardized measures used to assess specific symptoms, overall symptom burden, or health-related quality of life across institutions. Discordance exists between self-reported and actual access to local inpatient and outpatient PC services. Interpretation: Most ILD providers use PC and are comfortable discussing PC. Barriers to PC identified in this survey include the following: perceived lack of local access to PC, lack of systematic tools to assess symptom burden, lack of established optimal timing of PC referral, and unclear need for specialized PC delivery.
AB - Background: Interstitial lung disease (ILD) results in profound symptom burden and carries high mortality. Palliative care (PC) is dedicated to improving quality of life in patients with serious illness. Early PC provision improves rates of advance care planning and symptom management in patients with ILD. Research Question: What are the current perspectives on PC among ILD providers, and what are the barriers to PC in ILD specialty centers? Study Design and Methods: A 24-question electronic survey was disseminated to providers at the 68 Pulmonary Fibrosis Foundation Care Centers across the United States from October 2020 to December 2020. Results: The survey was completed by 128 participants representing all 68 Pulmonary Fibrosis Foundation Care Center Network sites. Most respondents were physicians. Most providers exhibit good knowledge of, feel comfortable assessing a patient's readiness for, and agree with the need for PC for patients with ILD. Providers are most likely to refer to PC at objective disease and/or symptomatic progression rather than at initial diagnosis. In comparison with providers who report referring their patients to PC, providers who report rare referral are more likely to cite lack local PC availability (P <.01) and less likely to feel comfortable discussing prognosis/disease trajectory (P =.03) or feel it is important to address advance directives in ILD clinic (P =.02). There is a lack of standardized measures used to assess specific symptoms, overall symptom burden, or health-related quality of life across institutions. Discordance exists between self-reported and actual access to local inpatient and outpatient PC services. Interpretation: Most ILD providers use PC and are comfortable discussing PC. Barriers to PC identified in this survey include the following: perceived lack of local access to PC, lack of systematic tools to assess symptom burden, lack of established optimal timing of PC referral, and unclear need for specialized PC delivery.
KW - interstitial lung disease
KW - palliative care
KW - pulmonary fibrosis
UR - http://www.scopus.com/inward/record.url?scp=85133813309&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85133813309&partnerID=8YFLogxK
U2 - 10.1016/j.chest.2022.03.009
DO - 10.1016/j.chest.2022.03.009
M3 - Article
C2 - 35305969
AN - SCOPUS:85133813309
SN - 0012-3692
VL - 162
SP - 375
EP - 384
JO - CHEST
JF - CHEST
IS - 2
ER -